Postprandial lipemia detects the effect of soy protein on cardiovascular disease risk compared with the fasting lipid profile

Lipids

Volumn 45, Issue 12, 2010, Pages 1127-1138

  Santo, Antonio S ^a,b   Santo, Ariana M ^c   Browne, Richard W ^d   Burton, Harold ^b   Leddy, John J ^b   Horvath, Steven M ^b   Horvath, Peter J ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Frye Regional Medical Center   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cardiovascular disease risk; Hypertriacylglycerolemia; Isoflavone rich soy; Isoflavones; Lipid profile; Milk protein; Phytoestrogens; Postprandial lipemia; Postprandial metabolism; Soy protein; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; FATTY ACID; GLUCOSE; ISOFLAVONE; LIPOPROTEIN; MILK PROTEIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET RESTRICTION; DIET SUPPLEMENTATION; DIETARY INTAKE; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; INTERMETHOD COMPARISON; LIPID BLOOD LEVEL; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; PARALLEL DESIGN; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; QUANTITATIVE ANALYSIS; SEDENTARY LIFESTYLE; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FASTING; HUMANS; HYPERLIPIDEMIAS; ISOFLAVONES; LIPID METABOLISM; LIPIDS; MALE; POSTPRANDIAL PERIOD; RISK FACTORS; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 78651078393     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-010-3487-z     Document Type: Article

References (63)

1. (2002) National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421
2. Adiels M, Packard C, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson S-O, Taskinen M-R, Borén J (2005) A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J Lipid Res 46:58-67
3. Allen JK, Becker DM, Kwiterovich PO, Lindenstruth KA, Curtis C (2007) Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women. Menopause 14:106-114
4. Anderson JW, O'Neal DS, Riddell-Mason S, Floore TM, Dillom DW, Oeltgen PR (1995) Postprandial serum glucose, insulin, and lipoprotein responses to high- and low-fiber diets. Metabolism 44:848-854
5. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. J Am Med Assoc 298:309-316
6. Caldwell CR, Britz SJ, Mirecki RM (2005) Effect of temperature, elevated carbon dioxide, and draught during seed development on the isoflavone content of dwarf soybean [Glycine max (L.) Merrill] grown in controlled environments. J Agric Food Chem 53:1125-1129
7. Cederroth CR, Nef S (2009) Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol 304:30-42
8. Cohn JS (2006) Postprandial lipemia and remnant lipoproteins. Clin Lab Med 26:773-786
9. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ (1988) Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29:469-479
10. Collaboration APCS (2004) Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific Region. Circulation 110:2678-2686
11. Coward L, Smith M, Kirk M, Barnes S (1998) Chemical modification of isoflavones in soy foods during cooking and processing. Am J Clin Nutr 68:1486s-1491s
12. De Bruin TWA, Brouwer B, Trip ML, Jansen H, Erkelens DW (1993) Different postprandial metabolism of olive oil and soybean oil: A possible mechanism of the high-density lipoprotein conserving effect of olive oil. Am J Clin Nutr 58:477-483
13. Dewell A, Hollenbeck PL, Hollenbeck CB (2006) Clinical review: A critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab 91:772-780
14. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG (2008) Nonfasting triglycerides and risk of ischemic stroke in the general population. J Am Med Assoc 300:2142-2152
15. Friedman M, Brandon DL (2001) Nutritional and health benefits of soy proteins. J Agric Food Chem 49:1069-1086
16. Gardner CD, Messina M, Kiazand A, Morris JL, Franke AA (2007) Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic adults: A randomized trial. J Am Coll Nutr 26:669-677
17. Ginsberg HN, Jones J, Blaner WS, Thomas A, Karmally W, Fields L, Blood D, Beg MD (1995) Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 15:1829-1838
18. Hanson LN, Engelman HM, Alekel DL, Schalinske KL, Kohut ML, Reddy MB (2006) Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr 84:774-780
19. Harris WS, Connor WE, Alam N, Illingworth DR (1988) Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res 29:1451-1460
20. Ho SC, Chen YM, Ho SS, Woo JL (2007) Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: A double-blind, randomized, placebo-controlled trial. Menopause 14:905-912
21. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A (2008) Flavonoids, flavonoidrich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am J Clin Nutr 88:38-50
22. Kannel WB, Vasan RS (2009) Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol 24:345-350
23. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A (1994) Postprandial lipoprotein and progression of coronary atherosclerosis. Atherosclerosis 106:83-97
24. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV (2005) Clinical relevance of postprandial lipaemia. Curr Med Chem 12:1931-1945
25. Langsted A, Freiberg JJ, Nordestgaard GB (2008) Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118:2047-2056
26. Le N-A, Walter MF (2007) The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 9:110-115
27. Levy E, Roy CC, Goldstein R, Bar-On H, Ziv E (1991) Metabolic fate of chylomicrons obtained from rats maintained on diets varying in fatty acid composition. J Am Coll Nutr 10:69-78
28. Lovati MR, Manzoni C, Corsini A, Granata A, Frattinin R, Fumagalli R, Sirtori CR (1992) Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture. J Nutr 122:1971-1978
29. Lu LW, Anderson K (1998) Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr 68:1500s-1504s
30. Ma Y, Chiriboga D, Olendzki BC, Nicolosi R, Merriam PA, Ockene IS (2005) Effect of soy protein containing isoflavones on blood lipids in moderately hypercholesterolemic adults: A randomized controlled trial. J Am Coll Nutr 24:275-285
31. Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH, Lichenstein AH (2007) Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 85:960-966
32. McVeigh BL, Dillingham BL, Lampe JW, Duncan AM (2006) Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr 83:244-251
33. Mora S, Rifai N, Buring JE, Ridker PM (2008) Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 118:993-1001
34. Muesing RA, Griffin P, Mitchell P (1995) Corn oil and beef tallow elicit different postprandial responses in triglycerides and cholesterol, but similar changes in constituents of high-density lipoprotein. J Am Coll Nutr 14:53-60
35. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. J Am Med Assoc 298:299-308
36. O'Keefe JH, Bell DSH (2007) Postprandial hyperglycemia/ hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100:899-904
37. Otvos JD, Jeyarajah EJ, CromwellWC(2002) Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 90:22i-29i
38. Parks EJ (2001) Recent findings in the study of postprandial lipemia. Curr Atheroscler Rep 3:462-470
39. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM, Patsch W (1992) Relation of triglyceride metabolism and coronary disease. Arterioscler Thromb 12:1336-1345
40. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB (2005) Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112:3375-3383 (Pubitemid 43739551)
41. Potter SM (1998) Soy protein and cardiovascular disease: The impact of bioactive components in soy. Nutr Rev 56:231-235
42. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J (2006) A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 98:633-640
43. Sacks FM (2006) The apolipoprotein story. Atheroscler Suppl 7:23-27
44. Sacks FM, Lichenstein A, Horn LV, Harris W, Kris-Etherton P, Winston M (2006) Soy protein, isoflavones, and cardiovascular health: An American Heart Association Science Advisory for health professionals from the Nutrition Committee. Circulation 113:1034-1044 (Pubitemid 43879479)
45. Santo AS, Cunningham AM, Alhassan S, Browne RW, Burton H, Leddy JJ, Grandjean PW, Horvath SM, Horvath PJ (2008) NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile. Appl Physiol Nutr Metab 33:489-500
46. Setchell K (1998) Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68:1333-1346
47. Sharret AR, Chambless LE, Heiss G, Paton CC, Patsch W (1995) Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. Arterioscler Thromb Vasc Biol 15:2122-2129
48. Shige H, Ishikawa T, Higashi K, Yamashita T, Tomiyasu K, Yoshida H, Hosoai H, Ito T, Nakajima K, Ayaori M, Yonemura A, Suzukawa M, Nakamura H (1998) Effects of soy protein isolate (SPI) and casein on the postprandial lipemia in normolipidemic men. J Nutr Sci Vitaminol 44:113-127
49. Sirtori CR, Calabresi L, Franceschini G (1999) Recombinant apolipoproteins for the treatment of vascular diseases. Atherosclerosis 142:29-40
50. Slavin JL, Karr SC, Hutchins AM, Lampe JW (1998) Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. Am J Clin Nutr 68:1492s-1495s
51. Sniderman AD, Furberg CD, Keech A, JERv Lennep, Frohlich J, Jungner I, Walldius G (2003) Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361:777-780
52. Stalenhoef AFH, Graaf Jd (2008) Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 19:355-361
53. Taku K, Umegaki K, Sato Y, Endoh K, Watanabe S (2007) Soy isoflavones lower serum total and LDL cholesterol in humans: A meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85:1148-1156
54. Thorp A, Howe PRC, Mori TA, Coates AM, Buckley JD, Hodgson J, Mansour J, Meyer BJ (2008) Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. Am J Clin Nutr 88:298-304
55. Torres N, Torre-Villalvazo I, Tovar AR (2006) Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem 17:365-373
56. Van Heek M, Zilversmit DB (1990) Postprandial lipemia and lipoprotein lipase in the rabbit are modified by olive and coconut oil. Arteriosclerosis 10:421-429
57. Wangen KE, Duncan AM, Xu X, Kurzer MS (2001) Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73:225-231
58. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL (1988) Dietary polyunsaturated fats of the w-6 and w-3 series reduce postprandial lipoproteins levels. J Clin Invest 82:1884-1893
59. Weissberg PL, Rudd JH (eds) (2002) Atherosclerotic biology and epidemiology of disease textbook of cardiovascular medicine. Lippincott Williams & Wilkins, Philadelphia
60. Yu KC-W, Cooper AD (2001) Postprandial lipoproteins and atherosclerosis. Front Biosci 6:d332-d354
61. Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397-408
62. Zhuo X-G, Melby MK, Watanabe S (2004) Soy isoflavone intake lowers serum LDL cholesterol: A meta-analysis of 8 randomized controlled trials in humans. J Nutr 134:2395-2400
63. Zilversmit DB (1979) Atherogenesis: A postprandial phenomenon. Circulation 60:473-485